CLINICAL_TRIALS
trial_result
· 2021-04-23
Clinical Trial Update: Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies [Phase 3]
Summary
Phase 3 study evaluating DCC-2618 (ripretinib) vs placebo in advanced gastrointestinal stromal tumor patients previously treated with anticancer therapies has c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Gastrointestinal Stromal Tumors | Phase 3 | Status: COMPLETED | Results posted: 2021-04-23